Human Heparanase-2(HPSE2) ELISA kit
-
中文名称:人乙酰肝素酶-2(HPSE2)酶联免疫试剂盒
-
货号:CSB-EL010717HU
-
规格:96T/48T
-
价格:¥3600/¥2500
-
其他:
产品详情
-
产品描述:人乙酰肝素酶-2(HPSE2)酶联免疫试剂盒(CSB-EL010717HU)为双抗夹心法ELISA试剂盒,定量检测血清、血浆、组织匀浆、细胞裂解物样本中的HPSE2含量。HPSE2是一个靶点。目前虽未给出更多信息,但一般而言,研究其背景或涉及在生理病理过程中的作用。研究机制方面可能聚焦于其分子结构、与其他分子相互作用、对细胞信号通路影响等,以探索其在疾病发生发展中的潜在机制与干预靶点价值。试剂盒检测范围为0.312 U/mL-20 U/mL,该产品可用于探究HPSE2在泌尿系统发育异常、组织纤维化或肿瘤微环境调控中的分子机制,亦适用于疾病模型研究或药物干预实验中靶点表达变化的动态监测,为HPSE2相关基础研究及转化医学提供标准化工具。本品仅用于科研,不用于临床诊断,产品具体参数及操作步骤详见产品说明书。
-
别名:HPSE2 ELISA Kit; HPA2 ELISA Kit; Inactive heparanase-2 ELISA Kit; Hpa2 ELISA Kit
-
缩写:HPSE2
-
Uniprot No.:
-
种属:Homo sapiens (Human)
-
样本类型:serum, plasma, tissue homogenates, cell lysates
-
检测范围:0.312 U/mL-20 U/mL
-
灵敏度:0.078 U/mL
-
反应时间:1-5h
-
样本体积:50-100ul
-
检测波长:450 nm
-
研究领域:Cancer
-
测定原理:quantitative
-
测定方法:Sandwich
-
数据处理:
-
货期:3-5 working days
相关产品
靶点详情
-
功能:Binds heparin and heparan sulfate with high affinity, but lacks heparanase activity. Inhibits HPSE, possibly by competing for its substrates (in vitro).
-
基因功能参考文献:
- The results of this study the Heparanase 2 appeared overexpressed at different stages of Alzheimer disease. PMID: 28387673
- our results suggest that heparanase 2 functions as a tumor suppressor in bladder cancer PMID: 26968815
- we provide evidence that Hpa2 overexpression in head and neck cancer cells markedly reduces tumor growth PMID: 27013193
- The most common HPA genotypes among Saudis were HPA-1 a + b- (75%), HPA-2 a + b- (62%), HPA-3 a + b- (51.5%), HPA-4 a + b- (99%), HPA-5 a + b- (76.5%), HPA-6 a + b- (100%) and HPA-15 a + b + (50%). The prevalent allele among the HPA systems was (a), except in the HPA-15 system where the (b) allele was found in 52% of the subjects. PMID: 27019315
- Our findings identified these 2 genes as a novel breast cancer biomarker gene set, which may facilitate the diagnosis and treatment in breast cancer clinical therapies. PMID: 26084486
- HPSE2 mutations were found in one Urofacial syndrome family but not detected in patients with non-neurogenic neurogenic bladder and severe lower urinary tract dysfunction PMID: 25924634
- Heparanase 2 is more intensely expressed in the glandular tissue of cancer than in nonneoplastic endometrium; the HPSE2 expression in the stromal tissue is higher in the nonneoplastic controls compared with cancer mainly in the secretory endometrium. PMID: 25423319
- autonomic neural protein implicated in bladder emptying PMID: 25145936
- High expression of heparanase-2 is associated significantly with gastric tumor growth and differentiation PMID: 24139593
- Data indicate that the overexpression of HPSE1 and HPSE2 in the intervertebral degenerated discs suggests a role for these factors in mediating extracellular matrix remodeling in degenerative discs during disease development. PMID: 23370684
- HPSE2 c.631T>C (p.Y211H) is a novel benign SNP and c.1628A>T (p.N543I) is the disease-causing mutation in urofacial syndrome. PMID: 21332471
- A large region of marker homozygosity was observed at 10q24, consistent with known autosomal recessive inheritance, family consanguinity and previous genetic mapping in other families with Ochoa syndrome. PMID: 21450525
- Studies indicate that cathepsin L as the heparanase activating protease. PMID: 21308479
- These results indicate a regulatory effect of heparanase on TFPI and TFPI-2 in trophoblasts, suggesting a potential involvement of heparanase in early miscarriages. PMID: 20031192
- We now report evidence that Heparanse 2 (HPSE2) is the culprit gene for the syndrome. Mutations with a loss of function in the Heparanase 2 (HPSE2) gene PMID: 20560209
- Homozygous exonic deletions, nonsense mutations, and frameshift mutations in five further unrelated families confirmed HPSE2 as the causative gene for UFS PMID: 20560210
- Results demonstrated that the effectors from heparanase peptide-immunized mice could effectively lyse various tumor cells that were heparanase positive and HLA-A*0201 matched. PMID: 20182872
- Heparanase 2 is involved in neoplastic proliferation, but it was not exclusively associated with the malignant process. PMID: 19955924
- Heparanase may facilitate invasion and metastasis of gastric carcinoma cells. PMID: 15475937
- Study demonstrating that increased heparanase expression in prostate cancer tissues is due to promoter hypomethylation and up-regulation of transcription factor EGR1. PMID: 15709168
- Heparanase expression seems to be involved in the invasiveness and aggressiveness of head and neck squamous cell carcinomas. PMID: 15837740
- Heparanase expression is inversely correlated with survival of nasopharyngeal carcinoma (NPC) patients, indicating heparanase is a reliable prognostic factor, and further supports that heparanase is a valid target for the development of anti-cancer drugs. PMID: 16879396
- HPSE plays a role in extracellular matrix remodeling and in increasing heparin-binding growth factor release during embryo implantation. PMID: 17989358
- Data suggest that loss of modified heparan sulphate in the GBM is mediated by an increased heparanase presence and may play a role in the pathogenesis of diabetes-induced proteinuria. PMID: 18058084
显示更多
收起更多
-
相关疾病:Urofacial syndrome 1 (UFS1)
-
亚细胞定位:Secreted, extracellular space, extracellular matrix.
-
蛋白家族:Glycosyl hydrolase 79 family
-
组织特异性:Widely expressed, with the highest expression in brain, mammary gland, prostate, small intestine, testis and uterus. In the central nervous system, expressed in the spinal chord, caudate nucleus, thalamus, substantia nigra, medulla oblongata, putamen and
-
数据库链接:
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-